| Literature DB >> 24865967 |
Jeroen Paardekooper Overman1, Jae-Sung Yi2, Monica Bonetti1, Matthew Soulsby2, Christian Preisinger3, Matthew P Stokes4, Li Hui4, Jeffrey C Silva4, John Overvoorde1, Piero Giansanti3, Albert J R Heck3, Maria I Kontaridis5, Jeroen den Hertog6, Anton M Bennett7.
Abstract
Noonan syndrome (NS) is an autosomal dominant disorder caused by activating mutations in the PTPN11 gene encoding Shp2, which manifests in congenital heart disease, short stature, and facial dysmorphia. The complexity of Shp2 signaling is exemplified by the observation that LEOPARD syndrome (LS) patients possess inactivating PTPN11 mutations yet exhibit similar symptoms to NS. Here, we identify "protein zero-related" (PZR), a transmembrane glycoprotein that interfaces with the extracellular matrix to promote cell migration, as a major hyper-tyrosyl-phosphorylated protein in mouse and zebrafish models of NS and LS. PZR hyper-tyrosyl phosphorylation is facilitated in a phosphatase-independent manner by enhanced Src recruitment to NS and LS Shp2. In zebrafish, PZR overexpression recapitulated NS and LS phenotypes. PZR was required for zebrafish gastrulation in a manner dependent upon PZR tyrosyl phosphorylation. Hence, we identify PZR as an NS and LS target. Enhanced PZR-mediated membrane recruitment of Shp2 serves as a common mechanism to direct overlapping pathophysiological characteristics of these PTPN11 mutations.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24865967 PMCID: PMC4135572 DOI: 10.1128/MCB.00135-14
Source DB: PubMed Journal: Mol Cell Biol ISSN: 0270-7306 Impact factor: 4.272